Van Eck Associates Corp Glaukos Corp Transaction History
Van Eck Associates Corp
- $78.1 Billion
- Q4 2024
A detailed history of Van Eck Associates Corp transactions in Glaukos Corp stock. As of the latest transaction made, Van Eck Associates Corp holds 1,134 shares of GKOS stock, worth $105,359. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,134
Previous 1,215
6.67%
Holding current value
$105,359
Previous $158,000
7.59%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding GKOS
# of Institutions
350Shares Held
48MCall Options Held
282KPut Options Held
401K-
Black Rock Inc. New York, NY8.04MShares$747 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.97MShares$555 Million0.02% of portfolio
-
State Street Corp Boston, MA2.06MShares$192 Million0.01% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN1.93MShares$179 Million0.08% of portfolio
-
Invesco Ltd. Atlanta, GA1.46MShares$136 Million0.04% of portfolio
About GLAUKOS Corp
- Ticker GKOS
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 47,596,900
- Market Cap $4.42B
- Description
- Glaukos Corporation, an ophthalmic medical technology and pharmaceutical company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent, iStent inject, iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-...